These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26594393)

  • 1. Comparison crystal structure conformations of two structurally related biphenyl analogues: 4,4'-bis-[3-(pyrrolidin-1-yl)prop-1-yn-1-yl]-1,1'-biphenyl and 4,4'-bis-{3-[(S)-2-methyl-pyrrolidin-1-yl]prop-1-yn-1-yl}-1,1'-biphen-yl.
    Wan A; Penthala NR; Fifer EK; Parkin S; Crooks PA
    Acta Crystallogr E Crystallogr Commun; 2015 Oct; 71(Pt 10):1147-50. PubMed ID: 26594393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of 4,4'-bis-[3-(piperidin-1-yl)prop-1-yn-1-yl]-1,1'-biphen-yl.
    Walbaum A; Fifer EK; Parkin S; Crooks PA
    Acta Crystallogr E Crystallogr Commun; 2017 Jun; 73(Pt 6):864-866. PubMed ID: 28638646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the crystal structures of 4,4'-bis-[3-(4-methyl-piperidin-1-yl)prop-1-yn-1-yl]-1,1'-biphenyl and 4,4'-bis-[3-(2,2,6,6-tetra-methyl-piperidin-1-yl)prop-1-yn-1-yl]-1,1'-biphen-yl.
    Wan A; Penthala NR; Fifer EK; Parkin S; Crooks PA
    Acta Crystallogr E Crystallogr Commun; 2015 Oct; 71(Pt 10):1132-5. PubMed ID: 26594389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of (E)-1-(4'-meth-oxy-[1,1'-biphen-yl]-4-yl)-3-(3-nitro-phen-yl)prop-2-en-1-one.
    Vidhyasagar T; Rajeswari K; Shanthi D; Kayalvizhi M; Vasuki G; Thiruvalluvar A
    Acta Crystallogr E Crystallogr Commun; 2015 Jan; 71(Pt 1):1-3. PubMed ID: 25705435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of (E)-1-([1,1'-biphen-yl]-4-yl)-3-(3-nitro-phen-yl)prop-2-en-1-one.
    Shanthi D; Vidhyasagar T; Rajeswari K; Kayalvizhi M; Vasuki G; Thiruvalluvar A
    Acta Crystallogr E Crystallogr Commun; 2015 Feb; 71(Pt 2):o119-20. PubMed ID: 25878861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of (E)-1-(4'-methyl-[1,1'-biphen-yl]-4-yl)-3-(3-nitro-phen-yl)prop-2-en-1-one.
    Vidhyasagar T; Rajeswari K; Shanthi D; Kayalvizhi M; Vasuki G; Thiruvalluvar A
    Acta Crystallogr E Crystallogr Commun; 2015 Jan; 71(Pt 1):o65-6. PubMed ID: 25705513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (E)-1-([1,1'-Biphen-yl]-4-yl)-3-(2-methyl-phen-yl)prop-2-en-1-one.
    Shanthi D; Vidhya Sagar T; Kayalvizhi M; Vasuki G; Thiruvalluvar A
    Acta Crystallogr Sect E Struct Rep Online; 2014 Jul; 70(Pt 7):o809-10. PubMed ID: 25161590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4,4'-Bis[(E)-(2,3-diiodo-prop-2-en-1-yl)-oxy]biphen-yl.
    Shah K; Raza Shah M; Ng SW
    Acta Crystallogr Sect E Struct Rep Online; 2011 Feb; 67(Pt 3):o568. PubMed ID: 21522331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-(4-Meth-oxy-phen-yl)-4,5-diphenyl-1-(prop-2-en-1-yl)-1H-imidazole.
    Akkurt M; Marzouk AA; Abbasov VM; Abdelhamid AA; Gurbanov AV
    Acta Crystallogr Sect E Struct Rep Online; 2012 Nov; 68(Pt 11):o3113-4. PubMed ID: 23284439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of 4'-{[4-(2,2':6',2''-terpyrid-yl-4'-yl)phen-yl]ethyn-yl}biphenyl-4-yl (2,2,5,5-tetra-methyl-1-oxyl-3-pyrrolin-3-yl)formate benzene 2.5-solvate.
    Meyer A; Schnakenburg G; Schiemann O
    Acta Crystallogr E Crystallogr Commun; 2015 Oct; 71(Pt 10):1245-9. PubMed ID: 26594417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of bis-(prop-2-yn-1-yl) 5-nitro-isophthalate.
    Ezhilarasi KS; Selvarani S; Rajakumar P; Revathi BK; Usha G
    Acta Crystallogr E Crystallogr Commun; 2015 Jun; 71(Pt 6):o435. PubMed ID: 26090213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4,4'-Bis(prop-2-yn-yloxy)biphen-yl.
    Zhang W; Yao L; Tao RJ
    Acta Crystallogr Sect E Struct Rep Online; 2007 Dec; 64(Pt 1):o307. PubMed ID: 21200870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Nitro-1,3-bis-(prop-2-yn-yl)-1H-1,3-benzimidazol-2(3H)-one.
    Kandri Rodi Y; Misbahi K; El-Ghayoury A; Zorina L; Essassi el M; El Ammari L
    Acta Crystallogr Sect E Struct Rep Online; 2013; 69(Pt 7):o1159. PubMed ID: 24046705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Bis[1-(prop-2-yn-yl)-1H-indol-3-yl]-1H-pyrrole-2,5-dione.
    Huang MH; Gao YC; Yang FL; Luo YJ
    Acta Crystallogr Sect E Struct Rep Online; 2013 Jun; 69(Pt 6):o924-5. PubMed ID: 23795093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,4-Bis{4-[bis-(prop-2-yn-1-yl)amino]-phen-oxy}benzene.
    Shah K; Raza Shah M; Ng SW
    Acta Crystallogr Sect E Struct Rep Online; 2011 Feb; 67(Pt 3):o567. PubMed ID: 21522330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,3'-{[(Biphenyl-2,2'-di-yl)bis-(methyl-ene)]bis-(-oxy)}bis-[N-(4-chloro-phen-yl)benzamide].
    Rajadurai R; Padmanabhan R; Meenakshi Sundaram SS; Ananthan S
    Acta Crystallogr Sect E Struct Rep Online; 2013 Jun; 69(Pt 6):o914-5. PubMed ID: 23795085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (2E)-3-(4-Methyl-phen-yl)-1-(3-nitro-phen-yl)prop-2-en-1-one.
    Jasinski JP; Butcher RJ; Narayana B; Lakshmana K; Yathirajan HS
    Acta Crystallogr Sect E Struct Rep Online; 2007 Dec; 64(Pt 1):o1-2. PubMed ID: 21200665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(5-Bromo-4-phenyl-1,3-thia-zol-2-yl)pyrrolidin-2-one.
    Ghabbour HA; Kadi AA; El-Subbagh HI; Chia TS; Fun HK
    Acta Crystallogr Sect E Struct Rep Online; 2012 Jun; 68(Pt 6):o1738-9. PubMed ID: 22719524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Hy-droxy-4-(prop-2-yn-yloxy)benz-alde-hyde.
    Selvarani V; Neelakantan MA; Silambarasan V; Velmurugan D
    Acta Crystallogr Sect E Struct Rep Online; 2013 Jan; 69(Pt 1):o64. PubMed ID: 23476445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,1-Bis(4-fluoro-phen-yl)-3,4-dihydro-1H-1,3-oxazino[3,4-a]indole.
    Fu W; Deng D; Hong D; Wang Z; Ji B
    Acta Crystallogr Sect E Struct Rep Online; 2008 Oct; 64(Pt 11):o2227. PubMed ID: 21581082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.